Network

Marjolein van der Klift

MD, PhD

  • Amphia Ziekenhuis
  • Amphia Hospital

External person

Hans Scheurer

  • Myeloma Patients Europe
  • Hematon

External person

Simone Oerlemans

  • Netherlands Comprehensive Cancer Organization (IKNL)

External person

Edward Laane

  • University of Tartu

External person

Saskia F.A. Duijts

  • Netherlands Comprehensive Cancer Organization (IKNL)
  • Vrije Universiteit Amsterdam
  • University of Amsterdam
  • Integraal Kankercentrum Nederland
  • Amsterdam UMC

External person

J Deursen

  • External organisation

External person

S Oerlemans

  • External organisation

External person

Birgit I. Lissenberg-Witte

  • Amsterdam UMC
  • Amsterdam Public Health Research Institute
  • Vrije Universiteit Amsterdam
  • VU University Medical Center

External person

Tatyana Ionova

  • St. Petersburg State University

External person

Sonja Zweegman

  • Vrije Universiteit Amsterdam
  • Amsterdam UMC
  • Jeroen Bosch Ziekenhuis
  • VU University Medical Center
  • Dept Hematol

External person

Claudia A. M. Stege

  • Vrije Universiteit Amsterdam
  • Amsterdam UMC
  • Erasmus University Rotterdam

External person

Solène Clavreul

  • Myeloma Patients Europe

External person

Tanja A. Stamm

prof.dr.

  • Ludwig Boltzmann Institute
  • Medical University of Vienna
  • Ludwig Boltzman Institute for Athritis and Rehabilitation

External person

Hans M. Westgeest

  • Amphia Hospital
  • VU University Medical Center

External person

Esther Natalie Oliva

  • Grande Ospedale Metropolitano “Bianchi-Melacrino-Morelli”
  • Harvard University

External person

LVV de Poll-Franse

  • External organisation

External person

Dorien Lobbezoo

  • Maastricht University Medical Center

External person

M Levin

  • External organisation

External person

Eva de Jongh

  • Albert Schweitzer Ziekenhuis
  • External organisation

External person

Aurore Perrot

  • University Cancer Institute
  • Institut Universitaire du Cancer de Toulouse
  • CHU de Toulouse
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna
  • Cancer University Institute Oncopole
  • Université de Toulouse III - Paul Sabatier

External person

Paul G Richardson

  • Hebrew SeniorLife
  • Dana-Farber Cancer Institute
  • Harvard University

External person

Mirjam M. Garvelink

  • St. Antonius Ziekenhuis

External person

Lars Bullinger

  • Charité – Universitätsmedizin Berlin
  • University Hospital Ulm
  • Berlin Institute of Health
  • German Cancer Consortium (DKTK); partner site Berlin

External person

Mattia D’Agostino

  • University of Turin
  • Azienda Ospedaliera - Universitaria Città della Salute e della Scienza di Torino

External person

D Vogels

  • External organisation

External person

Maria Teresa Lupo-Stanghellini

  • IRCCS Ospedale San Raffaele

External person

Mirian Brink

dr.

  • Netherlands Comprehensive Cancer Organization (IKNL)

External person

Katja C. Weisel

  • University Medical Center Hamburg-Eppendorf

External person

Sam Salek

  • University of Hertfordshire

External person

Mehul Dalal

  • DarwinHealth Inc.

External person

LW Tick

  • External organisation

External person

Femke Boersen

  • Amphia Hospital

External person

Jan Vesseur

  • Myeloma Patients Europe

External person

Heinz Ludwig

  • Klinik Ottakring
  • Wilhelminen Cancer Research Institute
  • Hematology

External person

Maarten R. Seefat

  • Vrije Universiteit Amsterdam
  • Amsterdam UMC
  • University of Amsterdam

External person

Lidwine Tick

  • Maxima Medical Centre
  • Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON)

External person

Daan Schoonen

  • Amphia Hospital

External person

Viorica Cursaru

  • European Myeloma Network Romania

External person

Christof Scheid

  • University Hospital Cologne
  • University of Cologne

External person

Belle H. de Rooij

  • Netherlands Comprehensive Cancer Organization (IKNL)
  • Tilburg University

External person